SCA
AMGN icon

Stonebridge Capital Advisors’s Amgen AMGN Stock Holding History

Stonebridge Capital Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-243
Closed -$65.2K – 240
2023
Q3 		$65.2K Sell
243
-173
-42% -$43.2K 0.01% 321
2023
Q2 		$92.3K Buy
416
+34
+9% +$7.89K 0.01% 281
2023
Q1 		$92.3K Sell
382
-510
-57% -$125K 0.01% 286
2022
Q4 		$234K Buy
892
+78
+10% +$20.9K 0.03% 187
2022
Q3 		$183K Buy
814
+40
+5% +$9.7K 0.02% 203
2022
Q2 		$188K Sell
774
-59
-7% -$14.5K 0.02% 206
2022
Q1 		$201K Sell
833
-17
-2% -$3.91K 0.02% 212
2021
Q4 		$191K Sell
850
-5
-0.6% -$1.05K 0.02% 209
2021
Q3 		$182K Sell
855
-791
-48% -$182K 0.02% 202
2021
Q2 		$405K Buy
1,646
+800
+95% +$197K 0.03% 190
2021
Q1 		$210K Buy
+846
New +$202K 0.03% 187
2020
Q4 		– Sell
-849
Closed -$216K – 190
2020
Q3 		$216K Hold
849
– – 0.04% 164
2020
Q2 		$200K Sell
849
-30
-3% -$6.84K 0.04% 166
2020
Q1 		$178K Buy
879
+30
+4% +$6.55K 0.04% 162
2019
Q4 		$205K Sell
849
-37
-4% -$8.16K 0.03% 180
2019
Q3 		$171K Hold
886
– – 0.03% 189
2019
Q2 		$163K Buy
+886
New +$159K 0.03% 191

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Stonebridge Capital Advisors's AMGN Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of Amgen (AMGN) in Q4 2023, closing a stake of 243 shares — an estimated $65.2K sold.

Stonebridge Capital Advisors first reported a position in AMGN in Q2 2019 and held it in 17 quarters. The position peaked at $405K in Q2 2021. 2,714 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

  • Stonebridge Capital Advisors reported no remaining Amgen position as of Q4 2023 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 243 Amgen shares in Q4 2023, an estimated $65.2K.
  • Stonebridge Capital Advisors first reported a position in Amgen in Q2 2019 and held it in 17 quarters.
  • Stonebridge Capital Advisors's Amgen position peaked at $405K in Q2 2021.
  • 2,714 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.